SANA Q1 2022 Earnings — Sana Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

SANASana Biotechnology, Inc.

$900M

Q1 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$32M

Net Income

-$31M

EPS (Diluted)

$-0.17

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$78M

Free Cash Flow

-$85M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$1.0B

Total Liabilities

$346M

Stockholders' Equity

$702M

Cash & Equivalents

$189M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$32M	-$181M	+82.5%
Net Income	-$31M	-$181M	+82.6%